abstract |
A pharmaceutical tablet by compression or a pharmaceutical tablet by direct compression, wherein the dispersion contains particles consisting of a DPP-IV inhibitor which is (S) -1 - [(3-hydroxy-1-adamantyl) amino] acetyl -2-cyano-pyrrolidine in free form or in the form of acid addition salt, and wherein at least 60% of the particle size distribution in the tablet is less than 250 µm. |